If an offering occurs after approval and is, as you say, necessary to keep operations going, it may result in a neutral to positive effect on the sp as the potential revenue for Xphozah is enormous. Based on what we know at this point it looks pretty good for the investors here. Ultimately I think we could see mid teens within a relatively short time after approval based on the expected revenue from Xphozah which should exceed 1b at peak.
News 
Market Data 
Discover 
AI
